Medrol

Methylprednisolone, the active ingredient in Medrol, is a glucocorticoid presented as an oral tablet for systemic use. It is employed to reduce inflammation and modify immune responses in a variety of inflammatory and autoimmune conditions.

GNH USA supplies Medrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methylprednisolone acts as a potent anti‑inflammatory and immunosuppressive agent across several disease families.

- Rheumatoid arthritis: decreases joint swelling, pain, and structural damage. - Asthma and chronic obstructive pulmonary diseases: improves airway function and reduces exacerbations. - Severe allergic reactions: rapidly mitigates systemic allergic inflammation. - Dermatologic inflammatory conditions: lessens skin redness, edema, and itching. - Autoimmune disorders: suppresses aberrant immune activity to control disease progression.

Methylprednisolone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Increased appetite or weight gain. - Elevated blood glucose levels. - Mood changes, including anxiety or insomnia. - Gastrointestinal discomfort or ulcer risk. - Fluid retention causing swelling. - Skin thinning or easy bruising.

Serious or Rare Side Effects: - Severe infections due to immune suppression. - Adrenal insufficiency on abrupt discontinuation. - Osteoporosis or bone fractures. - Vision problems such as cataracts or glaucoma. - Psychiatric disturbances like psychosis. - Uncontrolled hypertension.

Before initiating therapy, consider the following safety measures.

- Assess infection risk: screen for active or latent infections. - Monitor blood glucose: especially in diabetic patients. - Evaluate bone health: consider calcium and vitamin D supplementation. - Review psychiatric history: watch for mood alterations. - Check cardiovascular status: monitor blood pressure regularly. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Methylprednisolone can affect the activity of several concomitant medications.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase steroid levels. - Live vaccines: heightened risk of infection. - Anticoagulants (e.g., warfarin): potential for enhanced anticoagulant effect.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased gastrointestinal ulcer risk. - Diabetic agents: may require dose adjustment due to hyperglycemia. - Antihypertensives: possible reduction in blood pressure control.